Clinical trials in Leon – page 8

98 clinical trials in Leon, Spain across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in SpainEnsayosClinicos.es

Leon at a glance

clinical trials

Paediatric trials0
Research sites1

Quick filters

98 trials in Leon

Open in trial search

Plasma cell myeloma refractory

Not recruiting

Study Comparing Linvoseltamab to Elotuzumab, Pomalidomide, and Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma

Registered drugNo placebo

Study Comparing Linvoseltamab to Elotuzumab, Pomalidomide, and Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Dexamethasone
Sponsor:Regeneron Pharmaceuticals Inc.

Contact Research Centre

Coronary artery disease

Not recruiting

Study on Reduced Antiplatelet Therapy with Acetylsalicylic Acid and Clopidogrel for Patients with Coronary Artery Disease After Stent Implantation

Registered drugNo placebo

Study on Reduced Antiplatelet Therapy with Acetylsalicylic Acid and Clopidogrel for Patients with Coronary Artery Disease After Stent Implantation

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Acetylsalicylic Acid
Sponsor:Ivascular S.L.

Contact Research Centre

Chronic hepatitis B+1

Not recruiting

Study of Bepirovirsen for Patients with Chronic Hepatitis B on Nucleos(t)ide Analogue Treatment

Investigational

Study of Bepirovirsen for Patients with Chronic Hepatitis B on Nucleos(t)ide Analogue Treatment

Investigational

Spain

Participants:18–64 years · 65+ years
Substances:Bepirovirsen
Sponsor:Glaxosmithkline Research & Development Limited

Contact Research Centre

Hormone receptor positive HER2 negative breast cancer

Not recruiting

Study on Giredestrant or Tamoxifen for Premenopausal Women with Early ER-Positive, HER2-Negative Breast Cancer

Registered drugNo placebo

Study on Giredestrant or Tamoxifen for Premenopausal Women with Early ER-Positive, HER2-Negative Breast Cancer

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Giredestrant
Sponsor:Medica Scientia Innovation Research S.L.

Contact Research Centre

Endometrial cancer

Not recruiting

Study of Navtemadlin as Maintenance Therapy for Patients with Advanced or Recurrent Endometrial Cancer After Chemotherapy

Registered drug

Study of Navtemadlin as Maintenance Therapy for Patients with Advanced or Recurrent Endometrial Cancer After Chemotherapy

Registered drug

Spain

Participants:18–64 years · 65+ years
Substances:Loperamide
Sponsor:Kartos Therapeutics Inc.

Contact Research Centre

Marginal zone lymphoma+1

Not recruiting

Study Comparing Zanubrutinib, Obinutuzumab, and Rituximab with Lenalidomide and Rituximab for Patients with Relapsed or Refractory Follicular or Marginal Zone Lymphoma

Registered drugNo placebo

Study Comparing Zanubrutinib, Obinutuzumab, and Rituximab with Lenalidomide and Rituximab for Patients with Relapsed or Refractory Follicular or Marginal Zone Lymphoma

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Lenalidomide
Sponsor:BeOne Medicines AG

Contact Research Centre

Type 2 diabetes mellitus+2

Not recruiting

Study of Retatrutide for Patients with Type 2 Diabetes and Obesity or Overweight

Investigational

Study of Retatrutide for Patients with Type 2 Diabetes and Obesity or Overweight

Investigational

Spain

Participants:18–64 years · 65+ years
Substances:LY3437943 sodium
Sponsor:Eli Lilly & Co.

Contact Research Centre

Metastatic neoplasm

Not recruiting

Study on the Effectiveness of Tislelizumab and Spartalizumab in Patients with Advanced or Metastatic Cancer with High PD1 Biomarker Levels

Registered drugNo placebo

Study on the Effectiveness of Tislelizumab and Spartalizumab in Patients with Advanced or Metastatic Cancer with High PD1 Biomarker Levels

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Spartalizumab
Sponsor:Solti Group

Contact Research Centre

Plasma cell myeloma

Not recruiting

Study Comparing Selinexor, Pomalidomide, and Dexamethasone with Elotuzumab, Pomalidomide, and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma

Registered drugNo placebo

Study Comparing Selinexor, Pomalidomide, and Dexamethasone with Elotuzumab, Pomalidomide, and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Dexamethasone
Sponsor:European Myeloma Network B.V.

Contact Research Centre

Plasma cell myeloma

Not recruiting

Study of Belantamab Mafodotin, Carfilzomib, and Dexamethasone for Patients with Relapsed Multiple Myeloma Resistant to Lenalidomide

Registered drugNo placebo

Study of Belantamab Mafodotin, Carfilzomib, and Dexamethasone for Patients with Relapsed Multiple Myeloma Resistant to Lenalidomide

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Belantamab Mafodotin
Sponsor:Fundacion PETHEMA

Contact Research Centre

Plasma cell myeloma

Not recruiting

Study Comparing Lenalidomide, Bortezomib, Dexamethasone, Isatuximab, and Iberdomide for Newly Diagnosed Multiple Myeloma Patients Eligible for Stem Cell Transplant

Registered drugNo placebo

Study Comparing Lenalidomide, Bortezomib, Dexamethasone, Isatuximab, and Iberdomide for Newly Diagnosed Multiple Myeloma Patients Eligible for Stem Cell Transplant

Registered drugNo placebo

Spain

Participants:18–64 years
Substances:Bortezomib
Sponsor:Fundacion PETHEMA

Contact Research Centre

Study of fulvestrant and palbociclib combination for postmenopausal women with hormone receptor-positive metastatic breast cancer who completed 5 years of hormone therapy or have new metastatic disease

Registered drug

Study of fulvestrant and palbociclib combination for postmenopausal women with hormone receptor-positive metastatic breast cancer who completed 5 years of hormone therapy or have new metastatic disease

Registered drug

Spain

Participants:18–64 years · 65+ years
Substances:Fulvestrant
Sponsor:Fundacion Grupo Espanol De Investigacion En Cancer De Mama

Contact Research Centre

Other cities in Spain

The busiest research cities in the country

All 218 cities in Spain

Clinical research in Leon

What the registry says about research in the country

01 Oncology Research

Groundbreaking clinical trials targeting various types of cancer, including leukemia, lung cancer, and multiple myeloma. Studies focus on innovative therapeutic approaches combining immunotherapy with conventional treatments.

BCR-ABL1+ Chronic Myeloid Leukemia treatment studies
Advanced non-small cell lung cancer therapies
Multiple myeloma treatment innovations

Research includes evaluation of targeted therapies and novel drug combinations to improve patient outcomes.

02 Cardiovascular Studies

Comprehensive research investigating treatments for various heart conditions, with emphasis on coronary artery disease and prevention of cardiovascular events.

Antiplatelet therapy optimization
Spontaneous coronary artery dissection treatment
Major adverse cardiovascular event prevention

Studies aim to improve treatment strategies and reduce cardiovascular complications.

03 Metabolic and Emergency Medicine

Clinical research addressing urgent medical conditions and metabolic disorders, including septic shock and obesity management.

Weight management treatments
Septic shock interventions
Acute alcoholic hepatitis treatments

Focus on developing effective therapeutic approaches for critical conditions and metabolic disorders.

Back to Spain All countries